0.86% -0.0226

갈레라 테라 (GRTX)

개요 뉴스 가격 이력 옵션 체인 Financials GRTX 왜 하락? 토론 예측

Relative Volume:

갈레라 테라 Stock (GRTX) Company Profile

Galera Therapeutics Inc

Healthcare (1176)

Biotechnology (677)

최신 SEC 제출 서류

GRTX's Discussions on Twitter

GRTX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GRTX Galera Therapeutics Inc	0.0239	0	0	-69.68M	-48.93M	-1.89
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.50	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.16	26.89B	3.81B	-644.79M	-669.77M	-6.24

갈레라 테라 Stock (GRTX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-08-10	다운그레이드	Piper Sandler	Overweight → Neutral
2021-10-19	다운그레이드	BTIG Research	Buy → Neutral
2021-10-19	다운그레이드	BofA Securities	Buy → Underperform
2021-04-26	재개	Credit Suisse	Outperform
2020-12-16	업그레이드	Credit Suisse	Neutral → Outperform
2020-12-07	개시	H.C. Wainwright	Buy
2019-12-02	개시	BTIG Research	Buy
2019-12-02	개시	BofA/Merrill	Buy
2019-12-02	개시	Citigroup	Buy
2019-12-02	개시	Credit Suisse	Neutral

갈레라 테라 주식(GRTX)의 최신 뉴스

갈레라 테라 (GRTX) 재무 분석

갈레라 테라 (GRTX)

갈레라 테라 Stock (GRTX) Company Profile

GRTX을(를) 다른 주식과 비교

갈레라 테라 Stock (GRTX) Upgrades & Downgrades

갈레라 테라 주식(GRTX)의 최신 뉴스

U.S. Severe Oral Mucositis Market Projected To Witness - openPR.com

Radiation-induced Esophagitis Treatment Market Size in 7MM - openPR.com

Galera Therapeutics extends agreement deadline - Investing.com Australia

Galera Therapeutics extends agreement deadline By Investing.com - Investing.com South Africa

Galera Therapeutics Inc. (GRTX) reports earnings - qz.com

Radiotherapy Induced Oral Mucositis Treatment Market Size - openPR.com

Galera Therapeutics holds annual stockholder meeting By Investing.com - Investing.com South Africa

Galera Therapeutics holds annual stockholder meeting - Investing.com India

Oral Mucositis Market to Expand Significantly by 2034, States DelveInsight Report - EIN News

Galera Therapeutics Acquires Nova Pharmaceuticals to Advance Breast Cancer Treatment - MSN

Windtree Therapeutics Unveils New Strategy to Drive Revenue Growth - MyChesCo

Malvern-based Galera Therapeutics Secures New Lease on Life with Acquirement Underway - MSN

Immedica Pharma to Acquire Marinus Pharmaceuticals in $151 Million Deal - MyChesCo

Galera Therapeutics director Nancy Chang buys $499,978 in stock By Investing.com - Investing.com South Africa

St. Louis-born Galera Therapeutics sidesteps liquidation, acquires New York biotech company - The Business Journals

Galera Therapeutics director Nancy Chang buys $499,978 in stock - Investing.com

Festive biotech M&A spree sees Poolbeg combine with Hookipa, while Vincerx braces for layoffs - Fierce Biotech

Galera Therapeutics Completes Nova Pharmaceuticals Acquisition - citybiz

Galera Therapeutics sidesteps liquidation, acquires New York biotech company - The Business Journals

Galera Therapeutics Expands with Nova Pharmaceuticals Acquisition - TipRanks

Oncotelic Therapeutics Implements PDAOAI Platform - The Manila Times

Galera Therapeutics completes acquisition of Nova Pharmaceuticals - The Bakersfield Californian

Galera Therapeutics Acquires Nova Pharma, Pivots to Breast Cancer Drug Development with $3M Investment - StockTitan

Galera Therapeutics, Inc. acquired Nova Pharmaceuticals, Inc. - Marketscreener.com

Guardian Capital Partners Acquires Team LINX to Drive Growth in Technology Infrastructure - MyChesCo

FDA Tracker: 2024 Ends With Lilly’s Landmark GLP-1 Sleep Apnea Approval - BioSpace

Twelve option delistings on December 23rd - TipRanks

Layoff Tracker: Stubborn Layoff Trend Continues Across Biopharma in 2024 - BioSpace

Wayne’s Palvella Therapeutics Completes Reverse Merger with Pieris Pharmaceutical - VISTA.Today

Palvella Therapeutics and Pieris Pharmaceuticals Finalize Merger to Focus on Rare Disease Treatments - MyChesCo

Radiation Induced Esophagitis Market Set to Grow Substantially Through 2032, DelveInsight Projects | Galera Therapeutics - The Globe and Mail

Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Verrica Pharmaceuticals Grants Stock Option to New COO David Zawitz - MyChesCo

At galera.bet, we promote an agenda of integrity, compliance and - Oficjalny Portal Gminy Brzesko

Oral Mucositis Market expected to rise | Companies- Galera Therapeutics, Soligenix, Izun Pharma, MitoImmune Therapeutics, Tosk, Cellix Bio, Enzychem Lifesciences, Monopar Therapeutics - The Globe and Mail

Aclaris Therapeutics Secures Exclusive Licensing for Novel Antibody Therapies - MyChesCo

Aclaris Therapeutics Highlights Key Advances and Financial Results for Q3 2024 - MyChesCo

The 2024 Biotech Graveyard - Fierce Biotech

Oral Mucositis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Swedish Orphan Biovitrum, Galera Therapeutics, EpicentRx, Galera Therapeutics, Inc., Soligenix - Barchart

Galera stockholders reject liquidation plan - Investing.com

Oral Mucositis Clinical Trials 2024: FDA Approvals, - openPR

Mark Bachleda takes the helm at Eyconis - BioCentury

Eyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda - GlobeNewswire

Verrica Pharmaceuticals CEO to Present at Global Investment Conference - MyChesCo

Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewswire

Galera Therapeutics settles lawsuit for $975,000 - Investing.com

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Benzinga

Slone Partners Places Dr. Eugene P. Kennedy as Chief Medical Officer at Carisma Therapeutics - Hunt Scanlon Media

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - StockTitan

Galera Therapeutics Implements Stockholder Rights Plan to Shield Investor Interests - MyChesCo

Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer - PR Newswire

갈레라 테라 (GRTX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

GRTX과 유사한 종목